[Aortic valve replacement in a patient with chronic idiopathic thrombocytopenic purpura].
We reported a case of aortic valve replacement in a patient with chronic idiopathic thrombocytopenic purpura (ITP). We used high-dose intravenous gammaglobulin therapy (400 mg/kg/day) for five days to increase the platelet prior to the operation. The number of platelet was 8-10 x 10(4)/microliters at admission and it was increased to 23 x 10(4)/microliters before surgery. Aortic valve was replaced to SJM#21A prosthesis using cardiopulmonary bypass. The platelet was transfused after the bypass. Perioperative hemorrhage was moderate and postoperative course was uneventful. We believe that high-dose intravenous gammaglobulin therapy for ITP is effective to minimize perioperative hemorrhage for open heart surgery.
Tanaka
S
S
Department of Cardiovascular Surgery, Saisekai Maebashi Hospital, Japan.
Ishihara
S
S
Hara
S
S
Niinami
H
H
D000368:Aged; D001021:Aortic Valve / Q000601:surgery; D001024:Aortic Valve Stenosis / Q000150:complications / Q000601:surgery*; D002908:Chronic Disease; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications*
D016756:Immunoglobulins, Intravenous